InsidersTradesSigma
Track the PROTHENA CORPORATION PUBLIC LIMITED COMPANY stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €479m. The latest transaction was filed on 29 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: ANNE KINGSTON. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Prothena Corporation Public Limited Company is a biopharmaceutical company focused on the discovery and development of therapies for neurodegenerative diseases. It is listed on NASDAQ under the ticker symbol PRTA.